Analytik Jena Buys Assets of Insolvent MDx Firm SIRS-Lab | GenomeWeb

NEW YORK (GenomeWeb News) – Analytik Jena said today it has acquired all the assets of SIRS-Lab, a developer of molecular diagnostics for infectious diseases, which declared insolvency in December and had been seeking an investor to commercialize its lead product, a test for sepsis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.